Menu
Back to Journals » Cancer Management and Research » Volume 11
Original Research
Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,722 | Dovepress* | 10,195+ | 1,519 | 11,714 | |
| PubMed Central* | 2,527 | 558 | 3,085 | ||
| Totals | 12,722 | 2,077 | 14,799 | ||
| *Since 19 December 2018 | |||||
View citations on PubMed and Google Scholar